No presente estudo, pelas próprias características do Centro de Curativos, o perfil dos pacientes estudados representa, em sua maioria, quadros precoces e, portanto, de melhor prognóstico, o que em parte justifica o sucesso terapêutico observado: cicatrização de 85,7% das úlceras venosas e 80% das lesões de mal perfurante plantar num período inferior a dois meses.
Quando levamos em conta as doenças de base como insuficiência venosa, diabetes Mellitus e neuropatia pós-hansênica, como fatores dificultadores da reparação tecidual, foi possível constatar uma resposta cicatricial relativamente rápida nos casos descritos.
É importante, ainda, ressaltar a segurança da medicação utilizada, sem nenhum caso de efeitos colaterais sistêmicos ou eczema de contato observados, estando de acordo com dados da literatura.18
Estudos prospectivos, randomizados e comparativos entre a associação da Sulfadiazina de Prata a 1% e Nitrato de Cério a 0,4% e outras terapêuticas tópicas estão em andamento no sentido de consolidar a ação desta droga como agente facilitador da cicatrização tecidual.
REFERENCIAS BIBLIOGRÁFICAS
1. Falanga V et al: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured skin equivalent. ArchDermatol 1998:134:293-230.
2. Eriich KS, Rumack JS: Evaluation and management of nonhealing infected wouns in diabetics. Infect Med 1993;(10) 8: 21-27.
3. Oilin JW, Benstein Km, Childs MB, et al: Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med 1999;(1):1-7.
4. Falanga V: Venous ulceration. J Dermatol Surg Oncol 1993; 19:764-771.
5. Néizem O, Bergqvist D, Lindhagen A, Halboõk T: Cronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 1991;
45:184-187.
6. Fischer H: Venenleiden. Bine reprãsentative Untersuchung in der Bevõlkerung der Bundersrepublik Deutschiand (Tübinger Studie). München, Wien, Baltimore: Urban & Schwarzemberg, 1981.
7. Thomaz JB: Úlcera de estase venosa: concepção etiopatogênica e terapêutica. In: ThomazJ B: Síndromes Venosas-Diagnóstico e Tratamento, 1a ed. Rio de Janeiro, Revinter, 2001.
8. Bishop JB et al: A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc. Surg 1992;(16):251-257. |
9. Hindryckx PH, Cuyper C, Hendrickx B, Muilie A: The treatment of infected decubitus ulcers with 1% silver sulfadiazine cream. Curr Ther Rés 1990;(48)3:535-539.
10. Kucan JO, Robson MC, Heggers JP, Ko F: Comparison of siver sulfadiazine, povidoneiodine and physiologic saline in the treatment ofcronic pressure ulcers. J Am Ger Soe 1981; (29) 5:232-235.
11. Lioyde JR: Improvement of the management of skin grafts donor sites with silver sulfadiazine dressings. Arch Surg 1974: 561-565.
12. Boeckx W, Blondeel N, Vandersteen K, et al: Effect ofcerium nitrate-silver sulphadiazine on deep dermal burns: a histological hypothesis. Burns 1992; (18)6:456-462.
13. Melotte P, Hendrickx B, Melin P, et al: Efficacy of 1% silver-sulfadiazine cream in treating the bacteriological infection of leg ulcers. Curr Ther Rés 1985; (37):197-202.
14. Robson MC, Heggers JP: Delayed wound closers based on bacterial counts. J Surg Oncol 1970; (2):379.
15. Degreef H, Michieis JL: Silver sulfadiazine cream as a treatment for infected leg ulcers. Curr Ther Rés 1984;(36): l .190-1.194.
16. Geronemous RG, Mertz PM et Eagistein WH: Wound Healing - The effects of topical antimicrobial agents. Arch Dermatol 1979;(115):1.311-1.314.
17. Kjolseth D, Frank JM, Barker JH et al: Comparison of the effects of commonly used wound agents on epithelialization and neovascularizatíon.Am Coll Surg 1994;(179):305-312.
18. Degreef H, Dooms-Goosens A: Patch testing with silver sulphadiazine cream. Contact Dermatitis 1985;(12):33-37.
19. Fox CL, Monafo WW, Ayvazian et al: Topical chemotherapy for bums using cerium salts and silver sulfadiazine. Surg Gynecol Obstet 1977;(144): 668.
20. Hermans RP: Topical treatment ofserious infections with special reference to the use of a mixture of silver sulphadiazine and cerium nitrate: two clinical studies. Burns 1984; (l l): 59.
21. Monafo WW et al: Cerium nitrate: a new topic antisseptic for extensive burns. Surgery 1976;(80):465.
22. Sparkes BG, Monge G, Marshall S, et al: Plasma leveis of cutaneous burn toxin and lipid peroxides in termal injury. Burns 1990;(16):118.
23. Deveci M, Eski M et al: Effects of cerium nitrate bathing and prompt bum wound excision on I1-6 and TNF alpha levels in burned rats. Burns 2000; (6):41-45.
24. Jaschke E, Zabbernigg A, Gattringer C: Recombinant human granulocyte-macrophage colony-stimulanting factor applied locally in low doses enhances healing and prevenis recurrence of chronic venous ulcers. Intern J Dermatol 1999;(38):380-386.
Endereço para correspondência
Dr. Vagner Luis Desidério
Rua Sebastião Sampaio 1869
14160-600 - Sertãozinho - SP
clinicacirurg @ netsite.com.br |
